Trifecta-Heart cfDNA-MMDx Study
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- University of Alberta
- Study ID
- NCT04707872
- Status
- Recruiting
Conditions
- Heart Transplant Rejection
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MMDx diagnostic test — DIAGNOSTIC_TESTMicroarray test of gene expression in heart biopsies
- Prospera — DIAGNOSTIC_TESTDonor derived cell-free DNA in patient blood
- HLA antibody — DIAGNOSTIC_TESTCentralized measurement of HLA antibodies in patient blood
Study Details
Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.
Key Dates
- Start date
- Jun 1, 2021
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Heart transplant protocol and for cause biopsiesThe study population includes patients with a functioning heart transplant undergoing a biopsy for clinical indications as standard of care, or protocol biopsies of heart in high-risk patients, or follow-up after treatment.
Primary Outcome Measure
Calibration of Prospera test for T cell-mediated rejection [ Time Frame: 18 months ]
Central Contacts
- Konrad Famulski, PhD1 780 782 9463
- Robert Polakowski, PhD1 780 492 5091
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baptist Health Institute for Research and Innovation | Little Rock | Arkansas | 72205 | Victoria McIntosh Marren Patrick Campbell, MD (PRINCIPAL_INVESTIGATOR) |
| Tampa General Hospital, 409 Bayshore Blvd. | Tampa | Florida | 33606 | Kristyn Kuzianik Benjamin Mackie, MD (PRINCIPAL_INVESTIGATOR) |
| Columbia University Medical Center, Columbia Interventional Cardiovascular Care | West New York | New Jersey | 10032 | Maria Alejandra Muñoz Cifuentes Gabriel Sayer, MD (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL | The Bronx | New York | 10467 | Renae Robinson Brandon Johnson Omar Saeed, MD (PRINCIPAL_INVESTIGATOR) |
| Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute | Dallas | Texas | 75246 | Aayla K Jamil, MBBS Shelley Hall, MD (PRINCIPAL_INVESTIGATOR) |
| Cardiovascular Medicine, University of Utah Health | Salt Lake City | Utah | 84132 | Jennifer Hong Josef Stehlik, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Little Rock, AR
By research site
Baptist Health Institute for Research and Innovation· Little Rock, ARTampa General Hospital, 409 Bayshore Blvd.· Tampa, FLColumbia University Medical Center, Columbia Interventional Cardiovascular Care· West New York, NJMontefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL· The Bronx, NYAnnette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute· Dallas, TXCardiovascular Medicine, University of Utah Health· Salt Lake City, UT
Related Studies
- Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant RecipientsRecruiting · University of Florida · Coral Gables, Florida